Journal of Biosciences and Medicines

Volume 6, Issue 1 (January 2018)

ISSN Print: 2327-5081   ISSN Online: 2327-509X

Google-based Impact Factor: 0.87  Citations  

Main Microbial Genres and Its Profile of Resistance and Sensitivity to Antimicrobials Used in the Treatment of Oncological Patients with Febril Neutropenia

HTML  XML Download Download as PDF (Size: 1146KB)  PP. 34-50  
DOI: 10.4236/jbm.2018.61005    652 Downloads   1,075 Views  

ABSTRACT

Objective: To determine the main microbial genotypes and their antimicrobial resistance and susceptibility profile commonly used in the treatment of oncologic patients with febrile neutropenia, carried out through the review of the clinical histories of the patients’ medical records at the Hospital do Cancer de Muriaé-Fundacao Cristiano Varella. Methods: Quantitative research, determined the susceptibility profile of microorganisms in patients with febrile neutropenia from April 2007 to April 2008 by reviewing clinical histories of patients’ medical records at the referred hospital. Results: Of the total of 8 patients evaluated with Gram-negative microorganisms, 50% of the patients were female and 50% were male. Of the 18 patients evaluated with Gram-positive microorganisms 66% were female and 34% male. Gram-positive bacteria are prevalent and cause around 60% of documented bacteremias, although Gram-negative bacteria are more common in febrile neutropenic patientes. Conclusion: Exaggerated use of antimicrobials in hospitalized patients leads to the suppression of drug-sensitive microorganisms from the intestinal flora and promotes the persistence and growth of resistant bacteria. The antibiotic should be used in a curative manner with other therapeutic measures with the determined bacterial infection.

Share and Cite:

Póvoa, H. , Vieira, R. , Sathler, E. , Bernardes, I. , Ferreira, R. , Lima, M. , Miguel, T. , dos Anjos, N. , Rocha, L. and da Costa, D. (2018) Main Microbial Genres and Its Profile of Resistance and Sensitivity to Antimicrobials Used in the Treatment of Oncological Patients with Febril Neutropenia. Journal of Biosciences and Medicines, 6, 34-50. doi: 10.4236/jbm.2018.61005.

Cited by

No relevant information.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.